Results 14,921-14,940 of 27,251 for speaker:Richard Boyd Barrett

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: Mr. Lennon is saying that the Department does not trust GPs to prescribe a product that we are proposing-----

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: Mr. Lennon expressed concern about GPs.

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: What is the concern? Does Mr. Lennon think general practitioners are going to prescribe a dangerous product?

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: For epilepsy.

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: Mr. Lennon did not answer the question about pain.

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: Experts who know nothing about cannabis.

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: It is unfortunate that many of my questions have not been answered. I asked the following direct question. What specific expertise and knowledge does the Department of Health, the PSI or the HPRA have in the area of cannabis? I do not doubt that the organisations employs experts in their fields. I want to know who we have taken advice from. Are they experts who know nothing or a lot...

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: We do that.

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: I did not say that.

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: It was not implied.

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: He is misrepresenting what was said. It is really annoying.

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: It was not implied. I asked if they had expertise in the specific areas.

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: I would like some of my questions answered that have not yet been addressed.

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: Mr. Lennon did not answer them.

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: No, he has not.

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: I asked him a direct question about whether he believed it was acceptable that people with chronic pain who took medicinal cannabis products should continue to be criminalised and whether that was the effect of the access programme that he was proposing. It is a simple question and is in line with the-----

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: According to testimony given to the committee, chronic pain is being left out, the Department does not want to support the Bill and, therefore-----

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: No, I do not accept there is any process at all for people with chronic pain.

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: My other question was on EU countries that had adopted regimes with a wide access similar to what is proposed in the Bill, but the witnesses have given no explanation of what is wrong with those models and why the HPRA rejected them without argument or justification in its report and opted for regimes with more restrictive access programmes.

Joint Oireachtas Committee on Health: Cannabis for Medicinal Use Regulation Bill 2016: Discussion (Resumed) (13 Apr 2017)

Richard Boyd Barrett: Indeed we are.